Records containing: Recurrent Small Cell Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-11Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
-
CLINICAL_TRIALS study record update · 2024-04-02Activity and Enhancement of Immune Checkpoint Inhibition With Lurbinectedin in Relapsed/Recurrent Small Cell Lung Cancer (SCLC)
-
CLINICAL_TRIALS study record update · 2024-03-04Phase II Study of FR901228 in Patients With Refractory or Progressive Small Cell or Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2022-05-02Radiotherapy Combined With Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer (CREATE): A Open-label, Single-arm, Phase II Study
-
CLINICAL_TRIALS study record update · 2022-02-11A Phase II Study of Ponatinib in Cohorts of Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-04-14A Randomized Phase II Study of IV Topotecan Versus CRLX101 in the Second Line Treatment of Recurrent Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2019-11-18Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-11-07One-arm, Phase II, Single-center Clinical Study of Anlotinib in the Treatment of Recurrent Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-08-01Adapting Smoking Cessation Interventions for the Outpatient Oncology Setting
-
CLINICAL_TRIALS study record update · 2018-07-11Phase I/II Open Label Dose Escalation Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of SC16LD6.5 as a Single Agent in Patients With Recurrent Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-07-03A Pilot Study of Cryoablation for Patients With Oligometastatic Cancer Involving the Lung
-
CLINICAL_TRIALS study record update · 2018-07-03A Pilot Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Small Cell Lung Carcinoma (SCLC)
-
CLINICAL_TRIALS study record update · 2016-06-13Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2016-04-04A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 (Aflibercept; NSC-724770) in Patients With Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)
-
CLINICAL_TRIALS study record update · 2015-09-09A Phase II Study of UCN-01 in Combination With Topotecan in Patients With SCLC Who Relapsed or Progressed >= 3 Months After Completing First-Line Platinum-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2014-07-22Phase I/II Study of Obatoclax Mesylate (GX15-070MS), a Bcl-2 Antagonist, Plus Topotecan in Relapsed Small Cell Lung Carcinoma
-
CLINICAL_TRIALS study record update · 2014-04-10A Phase II Study of Single Agent Depsipeptide (FK228) (NSC 630176; IND 51,810) in Relapsed Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2014-03-31Randomized Single Institution Pilot Study of Vaccinia-CEA(6D)-TRICOM and Fowlpox-CEA(6D)-TRICOM With GM-CSF in Combination With Docetaxel in Patients With CEA-Bearing Cancers
-
CLINICAL_TRIALS study record update · 2014-02-11Phase II Study of the c-SRC Inhibitor AZD0530 After Four Cycles of Cytoreductive Chemotherapy for Patients With Extensive Stage Small Cell Lung Carcinoma
-
CLINICAL_TRIALS study record update · 2014-01-01Phase II Trial of XL119 (Rebeccamycin Analogue) in Relapsed "Sensitive" Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2013-10-08Phase II Trial of STI571 in Patients With Relapsed Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
-
CLINICAL_TRIALS study record update · 2013-06-04Phase I Trial of Interleukin-12 in Combination With Paclitaxel Plus Herceptin in Patients With Her2-positive Malignancies
-
CLINICAL_TRIALS study record update · 2013-04-26A Phase II Study of Dasatinib (NSC #732517) in Patients With Chemo-Sensitive Relapsed Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2013-03-21A Phase II Study of AT-101 in Recurrent Extensive Stage Small Cell Lung Cancer